Conversely, in BC this regulation is impaired for both BCR/ABL1 and BCR, which suggests the presence of ‘in trans’ deregulated transcription of both BCR and BCR/ABL1 promoters associated with CML progression [10]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.